These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 618824)

  • 1. Alterations in immune responsiveness in acute measles and chronic post-measles chest disease.
    Coovadia HM; Wesley A; Henderson LG; Brain P; Vos GH; Hallett AF
    Int Arch Allergy Appl Immunol; 1978; 56(1):14-23. PubMed ID: 618824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients.
    Okada H; Kobune F; Sato TA; Kohama T; Takeuchi Y; Abe T; Takayama N; Tsuchiya T; Tashiro M
    Arch Virol; 2000; 145(5):905-20. PubMed ID: 10881678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary nodular "pneumonia" during the acute atypical measles illness.
    Wood BP; Bernstein RM
    Ann Radiol (Paris); 1978; 21(2-3):193-8. PubMed ID: 677746
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological events in acute measles influencing outcome.
    Coovadia HM; Wesley A; Brain P
    Arch Dis Child; 1978 Nov; 53(11):861-7. PubMed ID: 727809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crippling lung disease after measles and adenovirus infection.
    Warner JO; Marshall WC
    Br J Dis Chest; 1976 Apr; 70(2):89-94. PubMed ID: 182195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological recovery after measles.
    Wesley A; Coovadia HM; Henderson L
    Clin Exp Immunol; 1978 Jun; 32(3):540-4. PubMed ID: 688697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoparesis and outcome in measles.
    Coovadia HM; Wesley A; Brain P; Henderson LG; Hallett AF; Vos GH
    Lancet; 1977 Mar; 1(8012):619-21. PubMed ID: 66426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinicoimmunological evaluation of the use of timogeksin in different forms of measles].
    Ershova IB
    Lik Sprava; 1997; (6):147-51. PubMed ID: 9589963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of treatment of acquired immunodeficiency in severe measles with thymic humoral factor.
    Beatty DW; Handzel ZT; Pecht M; Ryder CR; Hughes J; McCabe K; Trainin N
    Clin Exp Immunol; 1984 Jun; 56(3):479-85. PubMed ID: 6378450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological studies in children with chronic pulmonary infection.
    Wesley AG; Paren MA; Schonland M; Henderson L; O'Dowd PB
    S Afr Med J; 1976 Mar; 50(12):465-8. PubMed ID: 1273712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary complications in measles].
    BoroĊ„ P; Barszczewska I; Jezyna C; Kossakowski R; Lotocka K
    Wiad Lek; 1970 Oct; 23(19):1659-63. PubMed ID: 5477109
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines.
    Okada H; Sato TA; Katayama A; Higuchi K; Shichijo K; Tsuchiya T; Takayama N; Takeuchi Y; Abe T; Okabe N; Tashiro M
    Arch Virol; 2001; 146(5):859-74. PubMed ID: 11448026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts. The biology of measles in African children.
    Scheifele DW; Forbes CE
    East Afr Med J; 1973 Mar; 50(3):168-73. PubMed ID: 4724680
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity during natural measles infection.
    Whittle HC; Dossetor J; Oduloju A; Bryceson AD; Greenwood BM
    J Clin Invest; 1978 Sep; 62(3):678-84. PubMed ID: 308511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to measles in malnourished children.
    Whittle HC; Mee J; Werblinska J; Yakubu A; Onuora C; Gomwalk N
    Clin Exp Immunol; 1980 Oct; 42(1):144-51. PubMed ID: 6161724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further predictive indices of clinical severity of measles.
    Wesley AG; Coovadia HM; Kiepiela P
    S Afr Med J; 1982 May; 61(18):663-5. PubMed ID: 7079863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory T cells in measles. The relationship between reduced lymphocyte proliferative response to PHA and increased proportion of circulating suppressor-cytotoxic T cells.
    Bertotto A; Rambotti A; Gentilini F; Stefanelli M; Zucchetti P; Vaccaro R
    Microbiologica; 1984 Jan; 7(1):21-7. PubMed ID: 6233473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response in children with measles.
    Wesley AG; Hallett AF; Smythe PM
    S Afr Med J; 1975 Jan; 49(3):69-72. PubMed ID: 1114409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to and infant mortality from measles.
    Coovadia HM; Kiepiela P; Wesley AG
    S Afr Med J; 1984 Jun; 65(23):918-21. PubMed ID: 6729634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.